BDSX: Biodesix Inc Company Profile & Statistics

About

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.

Info & Links

CEO

Scott Hutton

Headquarters

919 WEST DILLON RD.
LOUISVILLE, CO 80027, UNITED STATES

Auditor

KPMG LLP

Share holders

239

Employees

217

Biodesix Inc Statistics

Valuation Measures

Market Capitalization²

226.93M

Enterprise Value

231.67M

Enterprise Value/EBITDA(ttm)

-8.95

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.02

Price to Book(mrq)

7.10

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

77.73%

Operating Margin(ttm)

-66.46%

Profit Margin(ttm)

-67.75%

Return on Equity(ttm)

-275.79%

Return on Invested Capital(ttm)

-99.36%

Return on Assets(ttm)

-43.05%

Income Statement

Revenue(ttm)

65.56M

Revenue Per Share(ttm)

0.45

Gross Profit(ttm)

50.96M

EBITDA(ttm)³

-25.87M

Net Income Available to Common(ttm)

-43.82M

Diluted EPS(ttm)

-0.39

Share Statistics

Beta (5Y Monthly)

1.14

52-Week Change

4.00%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

145.47M

Dividend Yield

0.00%

Float⁴

44.80M

% Held by Insiders

69.20%

% Held by Institutions

20.96%

Balance Sheet

Total Cash(mrq)

31.41M

Total Cash Per Share(mrq)

0.22

Total Debt(mrq)

36.14M

Total Debt/Equity(mrq)

129.74%

Current Ratio(mrq)

3.40%

Quick Ratio(mrq)

3.40%

Book Value Per Share(mrq)

0.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.30

Free Cash Flow(ytd)

-46.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BDSX

Biodesix Inc

Biodesix Inc Profile